GlassScriptPhysician profile
Derek S Damrow
NPI 1770016008
$3,466.07
in general payments reported to CMS, 2019-2025
13 companies · $475 in 2025
The $475 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.72 · 2022: $363 · 2023: $2,001 · 2024: $610 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,384 · Travel and Lodging: $702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,384.06 |
| Travel and Lodging | $702.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $1,262.02 | 2022-2025 | |
| Arthrex, INC. | $931.24 | 2023 | |
| Depuy Synthes Sales INC. | $412.30 | 2024-2025 | Na, Multiloc |
| Enduromed, LLC | $259.32 | 2023 | |
| Cgg Medical INC | $155.04 | 2023 | |
| Janssen Pharmaceuticals, INC | $141.32 | 2024-2025 | Spravato, Xarelto |
| E.R. Squibb & Sons, L.L.C. | $123.83 | 2022 | |
| Smith+Nephew, INC. | $76.25 | 2023 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Medical Device Business Services, INC. | $35.19 | 2024 | Attune |
| Exact Sciences Corporation | $23.74 | 2025 | Cologuard Collection Kit |
| Mid-Atlantic Surgical Systems, LLC | $16.72 | 2021 | |
| Collegium Pharmaceutical, INC. | $14.57 | 2023 | Belbuca |
| Glaxosmithkline, LLC. | $14.53 | 2024 | Shingrix, Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Damrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.